The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases

Molecular Biology of the Cell

Volumn 16, Issue 11, 2005, Pages 5215-5226

  Nour, Nadia ^a   Mayer, Gaétan ^a   Mort, John S ^b   Salvas, Alexandre ^a   Mbikay, Majambu ^c   Morrison, Charlotte J ^d   Overall, Christopher M ^d   Seidah, Nabil G ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; FURIN; HEPARIN; HEPARIN LYASE; PROPROTEIN CONVERTASE 5; PROTEIN PACE4; SURAMIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN COS1; CHEMICAL ANALYSIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DUODENUM; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LOCALIZATION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTESTINE CELL; JEJUNUM; LIVER SINUSOID; NONHUMAN; NULL CELL; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; CYSTEINE; HEPARITIN SULFATE; HUMANS; MEMBRANE PROTEINS; METALLOPROTEASES; MICE; PROPROTEIN CONVERTASE 5; PROPROTEIN CONVERTASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SERINE ENDOPEPTIDASES; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFECTION;

ANIMALIA;

EID: 27644458702     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E05-06-0504     Document Type: Article

References (70)

1. Abifadel, M., et al. (2003). Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34, 154-156.
2. Baker, A. H., Edwards, D. R., and Murphy, G. (2002). Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727.
3. Beaubien, G., Schafer, M. K., Weihe, E., Dong, W., Chretien, M., Seidah, N. G., and Day, R. (1995). The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates. Cell Tissue Res. 279, 539-549.
4. Benjannet, S., et al. (2001). Post-translational processing of β-secretase (β-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-β production. J. Biol. Chem. 276, 10879-10887.
5. Benjannet, S., et al. (2004). NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J. Biol. Chem. 279, 48865-48875.
6. Benjannet, S., Savaria, D., Laslop, A., Munzer, J. S., Chretien, M., Marcinkiewicz, M., and Seidah, N. G. (1997). α1-antitrypsin Portland inhibits processing of precursors mediated by proprotein convertases primarily within the constitutive secretory pathway. J. Biol. Chem. 272, 26210-26218.
7. Bergeron, E., Basak, A., Decroly, E., and Seidah, N. G. (2003). Processing of α4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage. Biochem. J. 373, 475-484.
8. Butler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., van Westrum, S. S., Crabbe, T., Clements, J., d'Ortho, M. P., and Murphy, G. (1998). The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273, 871-880.
9. Campan, M., Yoshizumi, M., Seidah, N. G., Lee, M. E., Bianchi, C., and Haber, E. (1996). Increased proteolytic processing of protein tyrosine phosphatase μ in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family. Biochemistry 35, 3797-3802.
10. Conesa, M., Prat, A., Mort, J. S., Marvaldi, J., Lissitzky, J. C., and Seidah, N. G. (2003). Down-regulation of αv/β3 integrin via misrouting to lysosomes by overexpression of a β3Lamp1 fusion protein. Biochem. J. 370, 703-711.
11. De Bie, I., Marcinkiewicz, M., Malide, D., Lazure, C., Nakayama, K., Bendayan, M., Seidah, N. G. (1996). The isoforms of proprotein convertase PC5 are sorted to different subcellular compartments. J. Cell Biol. 135, 1261-1275.
12. De Cat, B., Muyldermans, S. Y., Coomans, C., Degeest, G., Vanderschueren, B., Creemers, J., Biemar, F., Peers, B., and David, G. (2003). Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements. J. Cell Biol. 163, 625-635.
13. Dubois, C. M., Blanchette, F., Laprise, M. H., Leduc, R., Grondin, F., and Seidah, N. G. (2001). Evidence that furin is an authentic transforming growth factor-β1-converting enzyme. Am. J. Pathol. 155, 305-316.
14. Elagoz, A., Benjannet, S., Mammarbassi, A., Wickham, L., and Seidah, N. G. (2002). Biosynthesis and cellular trafficking of the convertase SKI-1/S1P: ectodomain shedding requires SKI-1 activity. J. Biol. Chem. 277, 11265-11275.
15. Fernandez-Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J. J., Lichte, A., Tschesche, H., and Maskos, K. (1998). Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 17, 5238-5248.
16. Fuki, I. V., Blanchard, N., Jin, W., Marchadier, D. H., Millar, J. S., Glick, J. M., and Rader, D. J. (2003). Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway. J. Biol. Chem. 275, 34331-34338.
17. Gangnon, F., Jegou, S., Vallarino, M., Vieau, D., and Vaudry, H. (2003). Molecular characterization of the cDNA and localization of the mRNA encoding the prohormone convertase PC5-A in the European green frog. J. Comp. Neurol. 456, 60-72.
18. Gauster, M., Hrzenjak, A., Schick, K., and Frank, S. (2005). Endothelial lipase is inactivated upon cleavage by the members of the proprotein convertase family. J. Lipid Res. 46, 977-987.
19. Gordon, V. M., Klimpel, K. R., Arora, N., Henderson, M. A., and Leppla, S. H. (1995). Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect. Immun. 63, 82-87.
20. Jaye, M., Lynch, K. J., Krawiec, J., Marchadier, D., Maugeais, C., Doan, K., South, V., Amin, D., Perrone, M., and Rader, D. J. (1999). A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21, 424-428.
21. Jean, F., Stella, K., Thomas, L., Liu, G., Xiang, Y., Reason, A. J., and Thomas, G. (1998). α1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc. Natl. Acad. Sci. USA 95, 7293-7298.
22. Jiang, Y., Goldberg, I. D., and Shi, Y. E. (2002). Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21, 2245-2252.
23. Jin, W., Fuki, I. V., Seidah, N. G., Benjannet, S., Glick, J., and Rader, D. J. (2005) Proprotein convertases are responsible for proteolysis and inactivation of endothelial lipase. J. Biol. Chem. (in press).
24. Jovine, L., Qi, H., Williams, Z., Litscher, E. S., and Wassarman, P. M. (2004). A duplicated motif controls assembly of zona pellucida domain proteins. Proc. Natl. Acad. Sci. USA 10J, 5922-5927.
25. Kai, H. S., Butler, G. S., Morrison, C. J., King, A. E., Pelman, G. R., and Overall, C. M. (2002). Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain. J. Biol. Chem. 277, 48696-48707.
26. Kalus, I., Schnegelsbeig, B., Seidah, N. G., Kleene, R., and Schachner, M. (2003). The proprotein convertase PC5A and a metalloprotease are involved in the proteolytic processing of the neural adhesion molecule L1. J. Biol. Chem. 278, 10381-10388.
27. Kitazume, S., Suzuki, M., Saido, T. C., and Hashimoto, Y. (2004). Involvement of proteases in glycosyltransferase secretion: Alzheimer's β-secretase-dependent cleavage and a following processing by an aminopeptidase. Glycoconj. J. 21, 25-29.
28. Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P., and Edwards, D. R. (1994). Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269, 9352-9360.
29. Lehmann, M., Rigot, V., Seidah, N. G., Marvaldi, J., and Lissitzky, J. C. (1996). Lack of integrin α-chain endoproteolytic cleavage in furin-deficient human colon adenocarcinoma cells LoVo. Biochem. J. 317, 803-809.
30. Lissitzky, J. C., Luis, J., Munzer, J. S., Benjannet, S., Parat, F., Chretien, M., Marvaldi, J., and Seidah, N. G. (2000). Endoproteolytic processing of integrin pro-α subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7. Biochem. J. 346, 133-138.
31. Lusson, J., Vieau, D., Hamelin, J., Day, R., Chretien, M., and Seidah, N. G. (1993). cDNA structure of the mouse and rat subtilisin/kexin-like PC 5, a candidate proprotein convertase expressed in endocrine and nonendocrine cells. Proc. Natl. Acad. Sci. USA 90, 6691-6695.
32. Marcinkiewicz, M., Day, R., Seidah, N. G., and Chretien, M. (1993). Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and α-melanotropin. Proc. Natl. Acad. Sci. USA 90, 4922-4926.
33. Mayer, G., Boileau, G., and Bendayan, M. (2003). Furin interacts with proMT1-MMP and integrin aV at specialized domains of renal cell plasma membrane. J. Cell Sci. 116, 1763-1773.
34. McCauley, T. C., Zhang, H. M., Bellin, M. E., and Ax, R. L. (2001). Identification of a heparin-binding protein in bovine seminal fluid as tissue inhibitor of metalloproteinases-2. Mol. Reprod. Dev. 58, 336-341.
35. McGregor, L., et al. (2003). Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat. Genet. 34, 203-208.
36. McQuibban, G. A., Gong, J. H., Tam, E. M., McCulloch, C. A., Clark-Lewis, I., and Overall, C. M. (2000). Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206.
37. Morgunova, E., Tuuttila, A., Bergmann, U., and Tryggvason, K. (2002). Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc. Natl. Acad. Sci. USA 99, 7414-7419.
38. Morrison, C. J., Butler, G. S., Bigg, H. F., Roberts, C. R., Soloway, P. D., and Overall, C. M. (2001). Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J. Biol. Chem. 276, 47402-47410.
39. Nachtigal, M. W., and Ingraham, H. A. (1996). Bioactivation of Mullerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. Proc. Natl. Acad. Sci. USA 93, 7711-7716.
40. Nakagawa, T., Murakami, K., and Nakayama, K. (1993). Identification of an isoform with an extremely large Cys-rich region of PC6, a Kex2-like processing endoprotease. FEBS Lett. 327, 165-171.
41. No, M., Raab, G., Lau, K., Abraham, J. A., Klagsbrun, M. (1994). Purification and characterization of transmembrane forms of heparin-binding EGF-like growth factor. J. Biol. Chem. 269, 31315-31321.
42. Nour, N., Basak, A., Chretien, M., and Seidah, N. G. (2003). Structure-Function Analysis of the prosegment of the proprotein convertase PC5A. J. Biol. Chem. 278, 2886-2895.
43. Oliva, A. A., Jr., Chan, S. J., and Steiner, D. F. (2000). Evolution of the prohormone convertases: identification of a homologue of PC6 in the protochordate amphioxus. Biochim. Biophys. Acta 1477, 338-348.
44. Overall, C. M., King, A. E., Sam, D. K., Ong, A. D., Lau, T. T., Wallon, U. M., DeClerck, Y. A., and Atherstone, J. (1999). Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV. J. Biol. Chem. 274, 4421-4429.
45. Overall, C. M., and Lopez-Otin, C. (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2, 657-672.
46. Pavlaki, M., Cao, J., Hymowitz, M., Chen, W. T., Bahou, W., and Zucker, S. (2002). A conserved sequence within the propeptide domain of membrane type 1 matrix metalloproteinase is critical for function as an intramolecular chaperone. J. Biol. Chem. 277, 2740-2749.
47. Puyraimond, A., Fridman, R., Lemesle, M., Arbeille, B., and Menashi, S. (2001). MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp. Cell Res. 262, 28-36.
48. Rancourt, S. L., and Rancourt, D. E. (1997). Murine subtilisin-like proteinase SPC6 is expressed during embryonic implantation, somitogenesis, and skeletal formation. Dev. Genet. 22, 75-81.
49. Rhee, D. K., Marcelino, J., Al Mayouf, S., Schelling, D. K., Bartels, C. F., Cui, Y., Laxer, R., Goldbach-Mansky, R., and Warman, M. L. (2005). Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing. J. Biol. Chem. 280, 31325-31332.
50. Rovere, C., Luis, J., Lissitzky, J. C., Basak, A., Marvaldi, J., Chretien, M., and Seidah, N. G. (1999). The RGD motif and the C-terminal segment of proprotein convertase 1 are critical for its cellular trafficking but not for its intracellular binding to integrin α5β1. J. Biol. Chem. 274, 12461-12467.
51. Seidah, N. G., Benjannet, S., Wickham, L., Marcinkiewicz, J., Jasmin, S. B., Stifani, S., Basak, A., Prat, A., and Chretien, M. (2003). The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc. Natl. Acad. Sci. USA 100, 928-933.
52. Seidah, N. G., and Chretien, M. (1999). Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848, 45-62.
53. Seidah, N. G., Chretien, M., and Day, R. (1994). The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 76, 197-209.
54. Seidah, N. G., and Prat, A. (2002). Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem. 38, 79-94.
55. Seo, D. W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B. Y., and Stetler-Stevenson, W. G. (2003). TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 224, 171-180.
56. Srour, N., Lebel, A., McMahon, S., Fournier, I., Fugere, M., Day, R., and Dubois, C. M. (2003). TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. FEBS Lett. 554, 275-283.
57. Stawowy, P., Graf, K., Goetze, S., Roser, M., Chretien, M., Seidah, N. G., Fleck, E., and Marcinkiewicz, M. (2003). Coordinated regulation and colocalization of αv integrin and its activating enzyme proprotein convertase PCS in vivo. Histochem. Cell Biol. 119, 239-245.
58. Stawowy, P., Kallisch, H., Veinot, J. P., Kilimnik, A., Prichett, W., Goetze, S., Seidah, N. G., Chretien, M., Fleck, E., and Graf, K. (2004). Endoproteolytic activation of α(v) integrin by proprotein convertase PC5 is required for vascular smooth muscle cell adhesion to vitronectin and integrin-dependent signaling. Circulation 209, 770-776.
59. Sternlicht, M. D., and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 27, 463-516.
60. Tam, E. M., Morrison, C. J., Wu, Y. I., Stack, M. S., and Overall, C. M. (2004). Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. USA 102, 6917-6922.
61. Tsuji, A., Sakurai, K., Kiyokage, E., Yamazaki, T., Koide, S., Toida, K., Ishimura, K., and Matsuda, Y. (2003). Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix. Biochim. Biophys. Acta 2645, 95-104.
62. Turk, B. E., Huang, L. L., Piro, E. T., and Cantley, L. C. (2001). Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat. Biotechnol. 19, 661-667.
63. Ulloa, L., Creemers, J. W., Roy, S., Liu, S., Mason, J., and Tabibzadeh, S. (2001). Lefty proteins exhibit unique processing and activate the MAPK pathway. J. Biol. Chem. 276, 21387-21396.
64. Wang, L., Yang, G., and Wu, X. (2004). Identification of the role of a cysteine-rich region of PC6B by determining the enzymatic characteristics of its mutants. Mol. Biotechnol. 27, 15-22.
65. Ward, C. W., Hoyne, P. A., and Flegg, R. H. (1995). Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor. Proteins 22, 141-153.
66. Wong, B. S., Liu, S., Schultz, G. A., and Rancourt, D. E. (2002). Subtilisin proprotein convertase-6 expression in the mouse uterus during implantation and artificially induced decidualization. Mol. Reprod. Dev. 62, 453-459.
67. Xiang, Y., Molloy, S. S., Thomas, L., and Thomas, G. (2000). The PC6B cytoplasmic domain contains two acidic clusters that direct sorting to distinct trans-Golgi network/endosomal compartments. Mol. Biol. Cell 22, 1257-1273.
68. Yamabhai, M., and Anderson, R. G. (2002). Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts. J. Biol. Chem. 277, 24843-24846.
69. Yana, I., and Weiss, S. J. (2000). Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell 11, 2387-2401.
70. Zucker, S., Drews, M., Conner, C., Foda, H. D., DeClerck, Y. A., Langley, K. E., Bahou, W. F., Docherty, A. J., and Cao, J. (1998). Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J. Biol. Chem. 273, 1216-1222.